UCSF buys former FibroGen tower in Mission Bay; dental school could move in with renovations starting in 2026.

Corinne Van Hoven, a senior honors medical diagnostics major, spent the summer conducting cancer research at Fox Chase Cancer ...

US pharma major Eli Lilly (NYSE: LLY) has reported positive topline data from its Phase III ATTAIN-MAINTAIN trial, showing that its oral GLP-1 candidate orforglipron helped patients maintain weight ...

Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.

Researchers from Marshall University and the University of Missouri have developed G2PDeep, an innovative web-based platform ...

Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM™ nanotechnology, today announced a major manufacturing ...

Looking for the stock market outlook for the first half of 2026? See what you should consider heading into the new year to help be prepared.

For one, interest rates are finally going down, with the Federal Reserve executing its latest cut on December 10. And ...

These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...